US Patent 7618817 Genetically modified human natural killer cell lines
Patent 7618817 was granted and assigned to Fox Chase Cancer Center (company) on November, 2009 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 7618817 Genetically modified human natural killer cell lines
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
